000 | 01112 a2200313 4500 | ||
---|---|---|---|
005 | 20250512204205.0 | ||
264 | 0 | _c19810810 | |
008 | 198108s 0 0 eng d | ||
022 | _a0071-9676 | ||
024 | 7 |
_a10.1159/000394383 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDavignon, J P | |
245 | 0 | 0 |
_aDelta-9-tetrahydrocannabinol: comments on antiemetic trials. _h[electronic resource] |
260 |
_bFrontiers of radiation therapy and oncology _c1980 |
||
300 |
_a148-56 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aDronabinol _xmetabolism |
650 | 0 | 4 | _aEuphoria |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntestinal Absorption |
650 | 0 | 4 |
_aNausea _xchemically induced |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
773 | 0 |
_tFrontiers of radiation therapy and oncology _gvol. 15 _gp. 148-56 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000394383 _zAvailable from publisher's website |
999 |
_c6263695 _d6263695 |